ArticleHaematologica2022

Response to Comment on: "Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients".

Jennifer R BrownPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.